BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

China-Africa medical cooperation broadens under BRI

From there, he can admire the breathtaking views of the sleek, curved structure and the intricately layered sunshade components, showcasing the marvels of ...

September 04, 2023 | News

Innovac Therapeutics Secures $18M Pre-A Funding for Lead Program Development

Innovac Therapeutics, an mRNA therapeutics company, announced the completion of an $18 million Series Pre-A financing. The financ...

September 04, 2023 | News

Sirnaomics' STP707 Shows Promise in Phase I Solid Tumor Study

Six cohorts, totaling 50 late-stage cancer patients, received STP707 four times monthly by intravenous infusion at escalating dosages. All cohorts demon...

September 01, 2023 | News

Epigenic Therapeutics Raises $32M for Breakthrough Epigenome Medicine Development

This round of financing will support the preclinical development and early clinical validation of two leading programs, discovery of future pipelines, expa...

August 30, 2023 | News

KeraLink International Reveals Innovative Plan to Eliminate Corneal Blindness

“KeraLink International is unique in our singular focus on bringing health care providers, technology innovators, philanthropists, and investors into...

August 29, 2023 | News

Specialised Therapeutics acquires commercialisation rights to new oral MND therapy

ST to partner with Dutch biotech company Treeway BV First CNS therapy in ST therapeutic portfolio The therapy is known as TW001 and is a un...

August 28, 2023 | News

Creative BioMart Updated Its R-PEAPC Conjugated Proteins for Research Use

R-PE Labeled Proteins are labeled products generated by combining R-PE fluorescent dyes with proteins. R-PE labeled protein is non-toxic, odorless, and has...

August 28, 2023 | News

BOC Sciences Introduces a Novel XDC Bioconjugation Platform to Advance Biomedical Research

The newly developed XDC bioconjugation platform offered by BOC Sciences introduces a range of advanced technologies and optimized protocols, revolutionizin...

August 25, 2023 | News

EU Commission Approves Pfizer's ABRYSVO™ for Infant and Elderly RSV Protection

Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has granted marketing authorization for ABRYSVO™, the company’s bival...

August 25, 2023 | News

PeptiGrowth & Orizuru Therapeutics Partner for Synthetic Peptide Growth Factor

OZTx, with the aim of social implementation of cell therapy products and innovative iPS cell-related technologies (platform innovation), is conducting rese...

August 25, 2023 | News

SK Bioscience and Vaxxas Partner for Needle-Free Typhoid Vaccine Patch

SK bioscience and Vaxxas have officially entered into a Joint Development Agreement. This collaboration is set to revolutionize vaccine delivery by devel...

August 24, 2023 | News

Lynk Pharma's LNK01001 Shows Positive Results in Ankylosing Spondylitis Phase II Trial

The study, led by Professor Xiaofeng Zeng, the director of the Department of Rheumatology and Immunology of Peking Union Medical College Hospital and ...

August 23, 2023 | News

MGI Partners with NGeneBio to Advance Precision Medicine

This strategic partnership will enable the integration of NGeneBio's advanced diagnostic assays with MGI's high-throughput sequencing technology to acceler...

August 23, 2023 | News

Everest Medicines' Partner Calliditas Therapeutics Gets FDA Priority Review for Nefecon® in IgA Nephropathy

"We congratulate our partner Calliditas for being granted priority review by the FDA for full approval and taking a step closer to offering this first-in-d...

August 22, 2023 | Regulatory

Stay Connected